**Core Concept**
Ergosterol biosynthesis is a crucial process in fungal cell membranes. Ergosterol is essential for maintaining membrane fluidity and structural integrity. Inhibiting ergosterol biosynthesis leads to fungal cell death, making this a target for antifungal therapy.

**Why the Correct Answer is Right**
The correct answer is the antifungal drug that does not inhibit ergosterol biosynthesis. The other options (A, B, and C) are all known to inhibit ergosterol biosynthesis, but the correct answer is different. This section will not reveal the correct answer yet.

**Why Each Wrong Option is Incorrect**
**Option A:** Amphotericin B actually interacts with ergosterol in the fungal cell membrane, not inhibiting its biosynthesis. Instead, it binds to ergosterol, creating pores that disrupt membrane integrity.

**Option B:** Clotrimazole is a triazole antifungal that inhibits lanosterol 14α-demethylase, a key enzyme in ergosterol biosynthesis.

**Option C:** Ketoconazole is another triazole antifungal that also inhibits lanosterol 14α-demethylase, similar to clotrimazole.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that different antifungal mechanisms can be used to treat various fungal infections. Understanding the specific mechanism of action of each antifungal is crucial for selecting the most effective treatment.

**Correct Answer: D. Amphotericin B.**